For Experts

It has been established that Propionibacterium acnes can interact with markers of innate immunity, such as Toll-like receptors (TLR) and protease-activated receptors (PAR).

Minocycline (Minolexin®) is a highly effective drug for the treatment of moderate papulopustular inflammatory acne. Minocycline combines well with topical therapies and enhances their effectiveness. It can be prescribed to both adults and children (approved for use from 8 years of age). Flexible dosing (50/100 mg/day) allows the drug to be used for extended periods.

According to international data, the incidence of diarrheal infections in industrialized countries is 0.5–2.0 episodes per person per year. The social and economic significance of acute intestinal infection (AII) is not limited to its high morbidity rate.

Minocycline (Minolexin®) is a highly effective drug for the treatment of moderate papulopustular inflammatory acne. Minocycline combines well with topical therapies and enhances their efficacy. It can be prescribed to both adults and children (approved for use from 8 years of age). Flexible dosing (50/100 mg per day) allows for long-term use of the drug.

The connection between allergic skin diseases and pathologies of the digestive, nervous, and endocrine systems has long been known and confirmed by numerous scientific studies and clinical practice. It has been established that the active antigenic stimulation, which the modern human body is constantly subjected to, transforms more readily from a monovalent to a polyvalent state in the presence of concomitant and numerous disorders in the gastrointestinal tract (GIT).

The prevention of allergies in young children is a pressing issue due to their high prevalence among infants in their first year of life, particularly those switched to formula feeding early. At the same time, it has been shown that despite the undeniable advantages of breastfeeding, manifestations of food intolerance can also occur in some (10-20%) breastfed children.

Among dermatological diseases, atopic dermatitis (AD) holds a special place in dermatology due to its still not fully understood etiopathogenesis, chronic course, and the associated therapeutic challenges.

Dysbiosis can be the cause of so-called adaptation diseases, which include the skin reaction to the introduction of new foods that occurs in infants during their first year of life. This reaction is officially designated as atopic dermatitis.